Onconetix, Inc.
ONCONASDAQHealthcare● Active
$1.01
$-0.02(-1.94%)
Market Cap$337369
P/E Ratio—
52W High$382.5
52W Low$0.91
Onconetix, Inc. (ONCO) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · ONCO · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.82M | $2.52M | $0.06M | $0.00M | $0.00M |
| Cost of Revenue | $0.18M | $1.47M | $1.19M | $0.01M | $0.00M |
| Gross Profit | $0.63M | $1.06M | ($1.13M) | ($0.01M) | ($0.00M) |
| Gross Margin %(computed) | 77.62% | 41.80% | — | — | — |
| Operating Expenses | |||||
| R&D Expenses | ($0.07M) | $0.15M | $1.95M | $4.13M | $1.33M |
| G&A Expenses | $7.04M | $11.23M | $14.77M | $9.35M | $2.09M |
| Total Operating Expenses | $6.98M | $57.54M | $34.91M | $13.48M | $3.42M |
| Operating Income | ($6.34M) | ($56.49M) | ($36.03M) | ($13.48M) | ($3.42M) |
| Operating Margin %(computed) | -778.16% | — | — | — | — |
| Interest Income | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Interest Expense | $0.75M | $1.41M | $0.67M | $0.00M | $0.00M |
| Income Before Tax | ($14.03M) | ($59.74M) | ($37.42M) | ($13.42M) | ($3.42M) |
| Income Tax Expense | $0.00M | ($1.05M) | ($0.01M) | $0.00M | $0.00M |
| Net Income | ($14.03M) | ($58.69M) | ($37.41M) | ($13.42M) | ($3.42M) |
| Net Margin %(computed) | — | — | — | — | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-4.73 | $-520.93 | $-25.03 | $-0.31 | $-0.09 |
| Wtd Avg Shares | 3.28M | 0.11M | 0.02M | 0.01M | 0.01M |
| EBITDA | ($13.27M) | ($57.60M) | ($36.71M) | ($13.41M) | ($3.41M) |
| EBITDA Margin %(computed) | — | — | — | — | — |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · M
Explore more Onconetix, Inc. data
About Onconetix, Inc. (ONCO) Income Statement
Onconetix, Inc. (ONCO) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, ONCO reported revenue of $0.00B, gross profit of $0.00B (gross margin 77.62%), and net income of ($0.01B) — a net profit margin of -1720.98%.
Frequently asked questions
ONCO · 4 questionsOnconetix, Inc. (ONCO) reported revenue of $0.00B for 2025, down 67.7% year-over-year.
ONCO revenueONCO salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09